Long‐Term Trends in Prescribing of Etizolam for Hypnotic Use in a Japanese University Hospital
Human Psychopharmacology: Clinical and Experimental · 2026-07 · 41 (4)
DOI: 10.1002/hup.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 23.06.2026. Verfasst von Mutsuhiro Nakao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Stress Management, Showa Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Diazepam, Practice Patterns, Physicians', Drug Prescriptions. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, KDDI Foundation, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Objectives
Etizolam is a short‐acting thienodiazepine widely prescribed for anxiety and insomnia despite increasing concerns regarding dependence and guideline recommendations limiting long‐term benzodiazepine use. This study examined long‐term prescribing trends of etizolam compared with benzodiazepine and non‐benzodiazepine hypnotics.
Methods
We conducted a retrospective database study including 16,886,524 prescriptions issued between April 2001 and March 2022 at a tertiary university hospital in Japan. Seventeen hypnotic agents were identified (10 benzodiazepines and 7 non‐benzodiazepines). Multivariable logistic regression was used to identify factors associated with prescribing hypnotic etizolam versus non‐benzodiazepine hypnotics.
Results
Among 124,179 etizolam prescriptions, 83,927 (67.6%) were issued for hypnotic use. Although the absolute number of prescriptions declined over time, the proportion prescribed for hypnotic use remained stable. The ratio of hypnotic etizolam prescriptions to non‐benzodiazepine hypnotics was higher in internal medicine than in psychiatry. In multivariable analysis, prescribing hypnotic etizolam was independently associated with internal medicine (adjusted OR 1.57), female sex, outpatient status, younger age, and earlier calendar year.
Conclusions
Despite declining overall use, etizolam continues to be prescribed as a hypnotic, particularly in non‐psychiatric settings. These findings highlight the persistence of specialty‐specific prescribing patterns and underscore the importance of targeted educational and policy interventions to promote safer hypnotic prescribing practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Stress Management, Showa Medical University, Tokyo, Japan.
- Graduate School of Medicine, Department of Hygiene, Public Health and Preventive Medicine, Showa Medical University, Tokyo, Japan.
- Centre for Information Science and Technology & Department of General Emergency Medicine, Northern Yokohama Hospital, Showa Medical University, Tokyo, Japan.
ORCID-Profile: Mutsuhiro Nakao
Förderung
- Ministry of Health, Labour and Welfare
- KDDI Foundation
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Nakao, M., Morohoshi, H., Kurata, Y., & Nakamura, A. (2026). Long‐Term Trends in Prescribing of Etizolam for Hypnotic Use in a Japanese University Hospital. Human Psychopharmacology: Clinical and Experimental, 41(4). https://doi.org/10.1002/hup.70053
Vancouver
Nakao M, Morohoshi H, Kurata Y, Nakamura A. Long‐Term Trends in Prescribing of Etizolam for Hypnotic Use in a Japanese University Hospital. Human Psychopharmacology: Clinical and Experimental. 2026;41(4). doi:10.1002/hup.70053
BibTeX
@article{Nakao2026,
author = {Nakao, Mutsuhiro and Morohoshi, Hokuto and Kurata, Yumiko and Nakamura, Akiou},
title = {Long‐Term Trends in Prescribing of Etizolam for Hypnotic Use in a Japanese University Hospital},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2026},
volume = {41},
number = {4},
doi = {10.1002/hup.70053}
}
EUVIMED